Use of Botulinum Toxin Type a in the Treatment of Spasticity

Matur Z., Parman Y. G.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, vol.47, pp.40-43, 2010 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 47
  • Publication Date: 2010
  • Doi Number: 10.4274/npa.y5929
  • Journal Name: NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.40-43
  • Keywords: Spasticity, botulinum toxin, upper motor neuron syndrome, stroke, LOWER-LIMB SPASTICITY, RANDOMIZED CONTROLLED-TRIAL, PLACEBO-CONTROLLED TRIAL, DOUBLE-BLIND, HEMIPARETIC PATIENTS, CEREBRAL-PALSY, STROKE, PATHOPHYSIOLOGY, LIMITATIONS, PARESIS
  • Bezmialem Vakıf University Affiliated: No

Abstract

Spasticity is a component of the upper motor neuron syndrome and occurs after maladaptive improvement. Velocity-dependent increase in muscle tonus causes restricted movement, muscle shortness, pain, joint malpositions and contractures. When spasticity is harmful, it has to be treated. The treatment of spasticity requires a multidisciplinary approach. Botulinum toxin type A is effective when used with other treatment modalities, especially with physiotherapy. (Archives of Neuropsychiatry 2010; 47 Supplement: 40-3)